Congresses

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Dr. Juan Manuel Pérez - 25 March, 2026 0

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 20 March, 2026 0

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

Dr. Juan Manuel Pérez - 18 March, 2026 0

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

International Meetings

CRT 2026

AHA 2025

TCT 2025

ESC 2025

EuroPCR 2025

SOLACI Meetings

SOLACI-SBHCI 23

SOLACI-SOCIME 22

SOLACI-CACI 21

SOLACI-SBHCI 19

SOLACI-SOCIME 18

Upcoming Events

CHIP LATAM: Complications Workshop

LATAM Valves 2026

SOLACI & SBHCI 2026

Last News

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Drugs for the Treatment of No-Reflow During PCI

Coronary revascularization before TAVI: prior PCI or conservative management?

Institutional News

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

Access